Department of Epidemiology, School of Public Health, University of Washington, Box 357236, Seattle, WA 98195, USA; International Agency for Research on Cancer, Section of Environment and Radiation, 150 Cours Albert Thomas, Lyon, 69372 Cedex 08, France.
J Clin Virol. 2013 Dec;58(4):696-702. doi: 10.1016/j.jcv.2013.10.012. Epub 2013 Oct 18.
HIV infection is associated with greater risk of precancerous lesions and cervical cancer in women. However, several factors remain unclarified regarding the association between HIV infection and HPV detection, especially among those with HIV type 2 versus type 1 infection and severely immunocompromised persons.
To evaluate HPV overall and type-specific detection among HIV-infected and uninfected women in Senegal.
Detection of HPV DNA for 38 genotypes in cervical swabs using PCR-based methods was evaluated in HIV-positive (n=467) and HIV-negative (n=2139) women participating in studies in Senegal. Among HIV-1 and/or HIV-2 positive women, CD4 counts were assessed. Adjusted multivariable prevalence ratios (PR) were calculated.
The prevalence of any HPV DNA and multiple HPV types was greater among HIV-infected individuals (78.2% and 62.3%, respectively) compared with HIV-negative women (27.1% and 11.6%). This trend was also seen for HPV types 16 and 18 (13.1% and 10.9%) compared to HIV-negative women (2.2% and 1.7%). HIV-infected women with CD4 cell counts less than 200 cells/μl had a higher likelihood of any HPV detection (PRa 1.30; 95% CI 1.07-1.59), multiple HPV types (PRa 1.52; 95% CI 1.14-2.01), and HPV-16 (PRa 9.00; 95% CI 1.66-48.67), but not HPV-18 (PRa 1.20, 95% CI 0.45-3.24) compared to those with CD4 counts 500 cells/μl or above.
HIV-infected women, especially those most severely immunocompromised, are more likely to harbor HPV. Measures to prevent initial HPV infection and subsequent development of cervical cancer through focused screening efforts should be implemented in these high risk populations.
HIV 感染会增加女性发生癌前病变和宫颈癌的风险。然而,HIV 感染与 HPV 检测之间的关联仍有一些尚未阐明的因素,特别是在 HIV 2 型与 1 型感染以及严重免疫功能低下的人群中。
评估塞内加尔 HIV 感染者和未感染者的 HPV 总体和型别特异性检测情况。
采用基于 PCR 的方法检测了 467 名 HIV 阳性和 2139 名 HIV 阴性女性宫颈拭子中的 38 种 HPV 基因型的 DNA。对 HIV-1 和/或 HIV-2 阳性女性进行了 CD4 计数评估。计算了调整后的多变量患病率比(PR)。
与 HIV 阴性女性(分别为 27.1%和 11.6%)相比,HIV 感染者中任何 HPV DNA 和多种 HPV 类型的流行率更高(分别为 78.2%和 62.3%)。与 HIV 阴性女性(分别为 2.2%和 1.7%)相比,HPV-16 和 HPV-18 也存在这种趋势(分别为 13.1%和 10.9%)。CD4 细胞计数小于 200 个/μl 的 HIV 感染者更有可能检测到任何 HPV(PRa 1.30;95%CI 1.07-1.59)、多种 HPV 类型(PRa 1.52;95%CI 1.14-2.01)和 HPV-16(PRa 9.00;95%CI 1.66-48.67),但 HPV-18 则不然(PRa 1.20,95%CI 0.45-3.24)。
HIV 感染者,尤其是那些免疫功能严重受损者,更有可能携带 HPV。应在这些高危人群中实施有针对性的筛查措施,以预防 HPV 的初始感染和随后宫颈癌的发生。